(Q34571869)

3 August 2017

1 reference

title

Repopulation of tumour cells between cycles of chemotherapy: a neglected factor (English)

1 reference

3 August 2017

1 reference

A J Davis

1

1 reference

PubMed ID

11905673

3 August 2017

J F Tannock

series ordinal

2

1 reference

3 August 2017

1 October 2000

1 reference

Lancet Oncology Commission

3 August 2017

1 reference

3 August 2017

1

1 reference

3 August 2017

86-93

1 reference

The effect of irradiation on function in self-renewing normal tissues with differing proliferative organisation.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Changes in the rate of repopulation during multifraction irradiation of mouse skin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Assessment and characterization of hemopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

The accelerated repopulation of a murine fibrosarcoma, FSA-II, during the fractionated irradiation and the linear-quadratic model

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Repair of sublethal radiation injury in hypoxic cells of a C3H mouse mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Cellular proliferation patterns in an experimental Rhabdomyosarcoma in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Tumour cell repopulation during fractionated radiotherapy: Correlation between flow cytometric and radiobiological data in three murine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirradiated tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Clinical evidence for tumor clonogen regeneration: interpretations of the data.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

The effect of treatment duration in the local control of cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Radiotherapy in Burkitt's lymphoma: conventional or superfractionated regime--early results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Improved treatment of a brain-tumor model. Part 1: Advantages of single- over multiple-dose BCNU schedules

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Cell-cycle phase-dependence of drug-induced cycle progression delay

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Tumor cell recruitment in the mouse adenocarcinoma EO 771 directly demonstrated by double labeling with [3H]- and [14C] thymidine and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Cell and environment interactions in tumor microregions: the multicell spheroid model

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Tumor resistance to therapy: a genetic or kinetic problem?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Schedule dependence for cisplatin and etoposide multifraction treatments of spheroids

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Conventional cancer therapy: promise broken or promise delayed?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900019-X

7 January 2021

10.1016/S1470-2045(00)00019-X

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11905673